'PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective' https://t.co/rnlzLSAzHV
PROTAC Degraders with Ligands Recruiting MDM2 E3 Ubiquitin Ligase: An Updated Perspective.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2022 – Jan 2024Where it's discussed
-
X / Twitter59 posts
-
News2 articles
-
YouTube1 videos
AI synopsis
What people are saying
The overall discussions reflect a positive outlook on the potential of MDM2-targeting PROTACs, with posters noting the article's relevance to advances in cancer treatment, reinforced by enthusiastic tone and keywords like 'updated perspective' and hashtags related to drug discovery. While some posts mainly share links and titles, others express genuine interest, indicating a broad but not deeply analytical engagement.
Most discussions recognize the significance of the research, with many sharing positive sentiments or supportive comments about the advances presented.
The comments demonstrate high interest, especially with the frequent use of hashtags like #ScienceOpen and #drugdiscovery, indicating engagement with the topic.
Many posts simply share links or references without deep analysis, but some include brief remarks, showing moderate engagement.
The repeated sharing and acknowledgment of the article suggest that the discussions acknowledge a noteworthy contribution to the field of cancer therapeutics.
Abstract in brief
- The text explains that MDM2 is an enzyme that degrades the tumor suppressor p53, and many inhibitors have been developed to block this process, but they often have limited success because of the complex feedback loop between MDM2 and p53.
- PROTACs (proteolysis targeting chimeras) are a new therapeutic approach that can overcome these limitations by promoting the degradation of MDM2 itself or other cancer-related proteins, using MDM2 as a target or as part of the degradation process.
- The review discusses recent advances in designing MDM2-based PROTAC drugs, highlighting their potential for effective cancer treatment and addressing future challenges in this emerging field.]
Top posts
Most liked on X and Bluesky#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJK3W
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
All mentions
Updated Perspective on MDM2 E3 Ubiquitin Ligase PROTAC Degraders
This video discusses an updated perspective on PROTAC degraders that target MDM2 E3 ubiquitin ligase, highlighting key advancements in drug discovery for human cancer. We explore the implications and potential…
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https…
RT @AMM_journal: PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https…
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJK3W
RT @AMM_journal: PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https…
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJK3W
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJK3W
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJK3W
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJK3W
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAi0N5W
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAi0N5W
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
'PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective' https://t.co/rnlzLSAzHV
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @XueHaibao: 'PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective' an article on #ScienceOpen: http…
'PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective' an article on #ScienceOpen: https://t.co/CBGOqFaMGq
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
RT @AMM_journal: #PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen htt…
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective an article on #ScienceOpen https://t.co/SbwhAhJceo
#PROTAC degraders with #ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective https://t.co/LmpciKrgsE
RT @AMM_journal: PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective https://t.co/oOaWIzWZfJ #drugdis…
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective https://t.co/oOaWIzWZfJ #drugdiscovery #humancancer https://t.co/Foit7gBXeU
RT @XueHaibao: 'PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective' an article on #ScienceOpen: http…
'PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective' an article on #ScienceOpen: https://t.co/CBGOqFrPIq
GL
AM
SR
YX
S
NB
MP
HX
CB